Immunisation with canarypox virus expressing rabies glycoprotein

The Lancet

Volumn 339, Issue 8807, 1992, Pages 1429-1432

  Cadoz, M ^a   Meignier, B ^a   Plotkin, S ^a   Strady, A ^b   Taylor, J ^c   Tartaglia, J ^c   Paoletti, E ^c  

^a Pasteur Merieux Serums et Vaccins   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

^c Virogenetics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KANAPOX; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADULT; ARTICLE; BIRD; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; MALE; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINIA VIRUS; VIRUS INFECTION;

ADULT; ANIMAL; ANTIBODIES, VIRAL; CANARIES; FEMALE; GENETIC VECTORS; GLYCOPROTEINS; HUMAN; MALE; MIDDLE AGE; NEUTRALIZATION TESTS; POXVIRIDAE; RABIES; RABIES VACCINES; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS;

EID: 0026762697     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(92)92027-D     Document Type: Article

References (21)

1. WHO meeting Geneva June 19-22 1989 Potential use of live viral and bacterial vectors for vaccines
2. Construction of poxviruses as cloning vectors/ insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus
3. Vaccinia virus: a selectable eukaryotic cloning and expression vector
4. Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine
5. Safety and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein
6. Recombinant fowlpox virus inducing protective immunity in non-avian species
7. Protective immunity against avian influenza induced by a fowlpox virus recombinant
8. Fowlpox virus as a vector in non-avian species
9. Non-replicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins
10. Fowlpox virus recombinant encoding the measles virus fusion protein: protection of mice against fatal measles encephalitis
11. Potential use of non-replicating vectors as recombinant vaccines
12. Efficacy studies on a canarypox-rabies recombinant virus
13. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene
14. Expression of rabies virus glycoprotein from a recombinant vaccinia virus
15. A rapid tissue culture test for determining rabies neutralizing antibody
16. Vaccinia virus as an expression vector
17. The complete DNA sequence of vaccinia virus
18. Appendix to "The complete DNA sequence of vaccinia virus"
19. A large scale antirabies immunization study in humans using HDCS vaccine: prophylactic vaccination using different routes of application and post-exposure treatment combined with and without simultaneous serum administration
20. Early/high and late/low responders among HDCS vaccinees
21. Overcoming inhibition of antibody responses to a malaria recombinant vaccinia virus caused by prior exposure to wild type virus